253 related articles for article (PubMed ID: 15620351)
41. Varicella-zoster virus open reading frame 47 (ORF47) protein is critical for virus replication in dendritic cells and for spread to other cells.
Hu H; Cohen JI
Virology; 2005 Jul; 337(2):304-11. PubMed ID: 15913699
[TBL] [Abstract][Full Text] [Related]
42. Herpes zoster in the first year of life following postnatal exposure to varicella-zoster virus: four case reports and a review of infantile herpes zoster.
Kurlan JG; Connelly BL; Lucky AW
Arch Dermatol; 2004 Oct; 140(10):1268-72. PubMed ID: 15492192
[TBL] [Abstract][Full Text] [Related]
43. Identification and characterization of 20 immunocompetent patients with simultaneous varicella zoster and herpes simplex virus infection.
Giehl KA; Müller-Sander E; Rottenkolber M; Degitz K; Volkenandt M; Berking C
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):722-8. PubMed ID: 18312326
[TBL] [Abstract][Full Text] [Related]
44. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
[TBL] [Abstract][Full Text] [Related]
45. Varicella-zoster virus glycoprotein oligosaccharides are phosphorylated during posttranslational maturation.
Gabel CA; Dubey L; Steinberg SP; Sherman D; Gershon MD; Gershon AA
J Virol; 1989 Oct; 63(10):4264-76. PubMed ID: 2550667
[TBL] [Abstract][Full Text] [Related]
46. Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts.
Shiraki K; Yoshida Y; Asano Y; Yamanishi K; Takahashi M
J Infect Dis; 2003 Dec; 188(12):1875-7. PubMed ID: 14673767
[TBL] [Abstract][Full Text] [Related]
47. Varicella-zoster virus: molecular virology and virus-host interactions.
Arvin AM
Curr Opin Microbiol; 2001 Aug; 4(4):442-9. PubMed ID: 11495809
[TBL] [Abstract][Full Text] [Related]
48. Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus method.
Tang YW; Allawi HT; DeLeon-Carnes M; Li H; Day SP; Schmid D
J Clin Virol; 2007 Oct; 40(2):129-34. PubMed ID: 17728179
[TBL] [Abstract][Full Text] [Related]
49. Allodynia in rats infected with varicella zoster virus--a small animal model for post-herpetic neuralgia.
Dalziel RG; Bingham S; Sutton D; Grant D; Champion JM; Dennis SA; Quinn JP; Bountra C; Mark MA
Brain Res Brain Res Rev; 2004 Oct; 46(2):234-42. PubMed ID: 15464211
[TBL] [Abstract][Full Text] [Related]
50. Studies on the polypeptides of varicella-zoster (V-Z) virus. II. Syntheses of viral polypeptides in infected cells.
Asano Y; Takahashi M
Biken J; 1980 Sep; 23(3):95-106. PubMed ID: 6257229
[TBL] [Abstract][Full Text] [Related]
51. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
[TBL] [Abstract][Full Text] [Related]
52. Varicella-zoster virus.
Sheff B
Nursing; 2000 Nov; 30(11):98. PubMed ID: 11111670
[No Abstract] [Full Text] [Related]
53. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
[TBL] [Abstract][Full Text] [Related]
54. Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus.
Jones JO; Arvin AM
Antiviral Res; 2005 Nov; 68(2):56-65. PubMed ID: 16118026
[TBL] [Abstract][Full Text] [Related]
55. [VARICELLA ZOSTER VIRUS AND DISEASES OF CENTRAL NERVOUS SYSTEM VESSELS].
Kazanova AS; Lavrov VF; Zverev VV
Zh Mikrobiol Epidemiol Immunobiol; 2015; (3):106-16. PubMed ID: 26259280
[TBL] [Abstract][Full Text] [Related]
56. Replication of varicella-zoster virus in human skin organ culture.
Taylor SL; Moffat JF
J Virol; 2005 Sep; 79(17):11501-6. PubMed ID: 16103201
[TBL] [Abstract][Full Text] [Related]
57. Distribution of varicella-zoster virus gpI and gpII and corresponding genome sequences in the skin.
Nikkels AF; Delvenne P; Debrus S; Sadzot-Delvaux C; Piette J; Rentier B; Piérard GE
J Med Virol; 1995 Jun; 46(2):91-6. PubMed ID: 7636508
[TBL] [Abstract][Full Text] [Related]
58. Infectibility of separated peripheral blood mononuclear cell subpopulations by varicella-zoster virus (VZV).
Koenig A; Wolff MH
J Med Virol; 2003; 70 Suppl 1():S59-63. PubMed ID: 12627490
[TBL] [Abstract][Full Text] [Related]
59. Prevention of shingles by varicella zoster virus vaccination.
Holodniy M
Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
[TBL] [Abstract][Full Text] [Related]
60. Development of varicella vaccine.
Takahashi M; Asano Y; Kamiya H; Baba K; Ozaki T; Otsuka T; Yamanishi K
J Infect Dis; 2008 Mar; 197 Suppl 2():S41-4. PubMed ID: 18419406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
